Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.

Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H

Open source

DOI
10.1093/carcin/bgs030
Published
2012 Apr
Container
Carcinogenesis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 37/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/carcin/bgs030,
  title = {Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.},
  author = {Hu Z and Dong J and Wang LE and Ma H and Liu J and Zhao Y and Tang J and Chen X and Dai J and Wei Q and Zhang C and Shen H},
  year = {2012},
  journal = {Carcinogenesis},
  doi = {10.1093/carcin/bgs030},
  url = {https://doi.org/10.1093/carcin/bgs030}
}

RIS

TY  - JOUR
TI  - Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
AU  - Hu Z
AU  - Dong J
AU  - Wang LE
AU  - Ma H
AU  - Liu J
AU  - Zhao Y
AU  - Tang J
AU  - Chen X
AU  - Dai J
AU  - Wei Q
AU  - Zhang C
AU  - Shen H
PY  - 2012
JO  - Carcinogenesis
DO  - 10.1093/carcin/bgs030
UR  - https://doi.org/10.1093/carcin/bgs030
ER  - 

APA

Z, H., J, D., LE, W., H, M., J, L., Y, Z., J, T., X, C., J, D., Q, W., C, Z., & H, S. (2012). Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.. Carcinogenesis. https://doi.org/10.1093/carcin/bgs030

Source records